Skip to main content
Genmab logo

Genmab — Investor Relations & Filings

Listed
Ticker · GMAB ISIN · DK0010272202 LEI · 529900MTJPDPE4MHJ122 CO Manufacturing
Open in API
Filings indexed 2,836 across all filing types
Latest filing 2026-03-16 Transaction in Own Shar…
Country DK Denmark
Listing CO GMAB · 20 venues

About Genmab

https://www.genmab.com/

Genmab is an international biotechnology company that specializes in the creation, development, and commercialization of differentiated antibody therapeutics. The company focuses on transforming the treatment of cancer and other serious diseases. By utilizing proprietary antibody technology platforms and scientific expertise, Genmab develops a pipeline of innovative medicines. Its activities span from discovery and research through clinical development to deliver novel therapies to patients.

Recent filings

Filing Released Lang Actions
Completion of Share Buy-back Program
Transaction in Own Shares Classification · 100% confidence The document is a formal company announcement from Genmab regarding the completion of a share buy-back program. It details the number of shares repurchased, the average price, and the total value of the transactions, and confirms the company's updated treasury share position. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2026-03-16 English
Completion of Share Buy-back Program
Transaction in Own Shares Classification · 100% confidence The document is a short company announcement (under 5,000 characters of core content) detailing the completion of a share buy-back program. It explicitly mentions that the program has been completed and provides a summary table of transactions. While it discusses share repurchases, the document structure—specifically the inclusion of an 'Attachment' link at the bottom—identifies it as a formal announcement regarding the publication of the detailed report, fitting the criteria for a Report Publication Announcement (RPA).
2026-03-16 English
Transactions in Connection with Share Buy-back Program
Transaction in Own Shares Classification · 100% confidence The document is a formal company announcement from Genmab detailing specific transactions executed under a share buy-back program. It provides a table of daily share repurchases, average prices, and total values, and updates the total number of treasury shares held by the company. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2026-03-09 English
Transactions in Connection with Share Buy-back Program
Transaction in Own Shares Classification · 100% confidence The document is a formal company announcement detailing specific transactions executed under a share buy-back program. It provides a table of daily share repurchases, average prices, and total values, and updates the company's total treasury share holdings. This aligns perfectly with the definition of 'Transaction in Own Shares' (POS), which covers reports of a company buying back its own shares.
2026-03-09 English
Correction to Company Announcement No. 13 of March 2, 2026
Director's Dealing Classification · 100% confidence The document is a formal notification of share transactions by company directors and executives (managerial employees). It details the acquisition of shares due to the vesting of restricted stock units, including the names of the individuals, their positions, the transaction price, and volume. This aligns perfectly with the definition of 'Director's Dealing' (DIRS), which covers reports of personal share transactions by company directors and executives.
2026-03-02 English
Correction to Company Announcement No. 13 of March 2, 2026
Director's Dealing Classification · 100% confidence The document is a correction to a previous announcement regarding transactions in company shares by managerial employees. It explicitly references 'transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons' and cites 'Article 19 of Regulation No. 596/2014 on Market Abuse'. This falls under the category of Director's Dealing (insider trades).
2026-03-02 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.